홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

1,5-Dibromopentane → HCID 19813041, 화합물

HRID 466962
노트
인쇄 미리보기

반응식

HRID 466962 반응식
[O:1]1[C:7]2[CH:8]=[CH:9][CH:10]=[CH:11][C:6]=2[CH2:5][NH:4][C:3](=[O:12])[CH2:2]1.[Br:13][CH2:14][CH2:15][CH2:16][CH2:17][CH2:18]Br.[H-].[Na+]>CN(C=O)C>[Br:13][CH2:14][CH2:15][CH2:16][CH2:17][CH2:18][N:4]1[CH2:5][C:6]2[CH:11]=[CH:10][CH:9]=[CH:8][C:7]=2[O:1][CH2:2][C:3]1=[O:12]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 81001,5-DibromopentaneHCID 24758Sodium hydrideHCID 9198014,5-dihydro-1,4-benzoxazepin-3(2H)-one

생성물 1

HCID 19813041HCID 19813041, 화합물수율 69.5%

시약·촉매·용매 1

HCID 6228Dimethylformamide용매

실험 절차

In 20 ml of DMF was dissolved 100 mg of 2,3,4,5-tetrahydro-1,4-benzoxazepin-3-one and the solution then ice-cooled. Then, to the resulting solution were added 0.125 ml (1.5 equivalent) of 1,5-dibromopentane and 29.4 mg (1.2 equivalent) of a 60% sodium hydride oil dispersion and the mixture was stirred for 1.5 hour with ice-cooling. Thereafter, the reaction solution was reacted and/or treated and purified in the same manner as in Reference Example 1 to give 133 mg (yield: 69.5%) of the title compound.

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트

후처리

  1. temperaturethe solution then ice-cooled
  2. temperaturecooling
  3. customThereafter, the reaction solution was reacted
  4. additiontreated
  5. custompurified in the same manner as in Reference Example 1

출처 및 근거

ORD 기록
ord-4eb6000349294b12b5bc7408be8ee0a7
출처 데이터셋
uspto-grants-1992_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US05158947

반응 노트

불러오는 중…